273 research outputs found
Metal-assisted red light-induced DNA cleavage by ternary L-methionine copper(II) complexes of planar heterocyclic bases
Ternary copper(II) complexes [Cu(L-met)B(Solv)](ClO4) (1-4), where B is a N,N-donor heterocyclic base like 2,2-bipyridine (bpy, 1), 1,10-phenanthroline (phen, 2), dipyrido[3,2-d:2',3'-f]quinoxaline (dpq, 3) and dipyrido[3,2-a:2',3'-c]phenazene (dppz, 4), are prepared and their DNA binding and photoinduced DNA cleavage activity studied (L-Hmet=L-methionine). Complex 2, structurally characterized by X-ray crystallography, shows a square pyramidal (4+1) coordination geometry in which the N,O-donor L-methionine and N,N-donor heterocyclic base bind at the basal plane and a solvent molecule is coordinated at the axial site. The complexes display a d-d band at ~600 nm in DMF and exhibit a cyclic voltammetric response due to the Cu(II)/Cu(I) couple near -0.1 V in DMF-Tris-HCl buffer. The complexes display significant binding propensity to the calf thymus DNA in the order: 4 (dppz) > 3 (dpq) > 2 (phen) » 1 (bpy). Control cleavage experiments using pUC19 supercoiled DNA and distamycin suggest major groove binding for the dppz and minor groove binding for the other complexes. Complexes 2-4 show efficient DNA cleavage activity on UV (365 nm) or red light (632.8 nm) irradiation via a mechanistic pathway involving formation of singlet oxygen as the reactive species. The DNA cleavage activity of the dpq complex 3 is found to be significantly more than its dppz and phen analogues
6,8-Dibromo-5-hydroxy-4-oxo-2-phenyl-4H-chromen-7-yl acetate
In the title compound, C17H10Br2O5, the chromene ring is almost planar with minimal puckering [total puckering amplitude = 0.067 (4) Å]. The dihedral angle between chromeme ring system and phenyl ring is 3.7 (2)°. The crystal structure is stabilized by intermolecular C—H⋯O interactions and an intramolecular O—H⋯O hydrogen bond also occurs
5,7-Dimethoxy-2-phenyl-4H-chromen-4-one
The asymmetric unit of the title compound, C17H14O4, contains two independent molecules which differ in the relative orientations of the phenyl rings with repect to the essentially planar [maximum deviations of 0.029 (2) and 0.050 (2) Å in the two molecules] chromene fused-ring system, forming dihedral angles of 10.3 (5) and 30.86 (5)° in the two molecules. The crystal structure is stabilized by weak C—H⋯O and C—-H⋯π interactions, and π–π stacking interactions
5,7-Bis(benzyloxy)-2-phenyl-4H-chromen-4-one
In the title compound, C29H22O4, the chromene ring is almost planar with a small puckering [0.143 (2) Å]. The crystal structure is stabilized by C—H⋯O and C—H⋯π interactions. Edge-to-face (centroid–centroid distances of 3.894 and 3.673 Å) and face-to-face (centroid–centroid distance of 3.460 Å) π–π-ring electron interactions are also observed
Dimethyl 2,2′-[(4-oxo-2-phenyl-4H-chromene-5,7-diyl)dioxy]diacetate: a more densely packed polymorph
The title molecule, C21H18O8, crystallizes in two crystal polymorphs, see also Nallasivam, Nethaji, Vembu & Jaswant [Acta Cryst. (2009), E65, o314–o315]. The molecules of both polymorphs differ by the conformation of the oxomethylacetate groups. The title molecules are rather planar compared to the molecules of the other polymorph. In the title molecule, one of the oxomethylacetate groups is disordered (occupancies of 0.6058/0.3942). The structures of both polymorphs are stabilized by C—H⋯O and C—H⋯π interactions. Due to the planarity of the title molecules and similar intermolecular interactions, the title molecules are more densely packed than those of the other polymorph
Synthesis, structure analysis, Hirshfeld surface studies, molecular docking studies against cyclin-dependent kinases (CDKs) of sulfonamide decorated N6-benzyl aminopurines for cancer treatment
Cyclin-dependent kinases (CDKs) are recognized as the primary regulators of the cell cycle. CDKs are over-expressed in various types of cancer. Inhibiting CDKs with small molecules can reduce tumor growth and benefit cancer patients. In the current study, sulfonamide-decorated N6-benzyl aminopurines such as ligand 1: (α- alpha (Purin-6-ylamino)-p-toluenesulfonamide) and ligand 2: (α-(2-Amino purin-6-ylamino)-p-toluenesulfonamide)) purine were synthesized and explored for their anticancer efficacy. Crystallographic analysis revealed that ligand 1 crystallizes in P-1 of the triclinic and ligand 2 molecule in C2/c or P21/c of the monoclinic systems. Hirshfeld surface and X-ray crystallographic studies discovered that ligand 2 possesses stronger noncovalent interaction ability than roscovitine. In silico analysis showed that ligand 2 had a higher binding affinity for ATP binding sites of CDK1, CDK2, and CDK4 receptors than roscovitine (a known CDK inhibitor). The enhanced binding affinity of ligand 2 with CDKs was found to be associated with strong noncovalent interactions between ligand 2 and specific amino acids in CDKs. Cytotoxicity studies were conducted on the glioblastoma cell line (U251) by incubating cells with ligands 0, 1, and 2, roscovitine, and the established anticancer drug Temozolomide (TMZ). Ligand 2 (66.12 ± 1.09 µM) demonstrated better cytotoxicity compared to ligand 1 (81.22 ± 0.30 µM), roscovitine (127.10 ± 0.47 µM), and TMZ (165.11 ± 1 µM). It was well known that CDK inhibition can lead to cell cycle arrest. Intriguingly, ligand 2 induced G2/M phase cell cycle arrest by increasing the percentage of the G2/M phase cell population from 21.08 % to 47.79 % in U251 cells. Based on these results, ligand 2 showed anticancer properties by binding to the ATP binding site of CDKs. Hence, ligand 2 can serve as a potential lead molecule in the development of effective anticancer agents
Synthesis and crystal structure of copper (II) uracil ternary polymeric complex with 1,10-phenanthroline along with the Hirshfeld surface analysis of the metal binding sites for the uracil ligand
The study of models for ``metal-enzyme-substrate'' interaction has been a proactive area of research owing to its biological and pharmacological importance. In this regard the ternary copper uracil complex with 1,10-phenanthroline represents metal-enzyme-substrate system for DNA binding enzymes. The synthesis of the complex, followed by slow evaporation of the reaction mixture forms two concomitant solvatomorph crystals viz., {Cu(phen)(mu-ura)(H2O)](n)center dot H2O (1a)} and {Cu(phen)(mu-ura)(H2O)](n)center dot CH3OH (1b)}. Both complexes are structurally characterized, while elemental analysis, IR and EPR spectra were recorded for 1b (major product). In both complexes, uracil coordinates uniquely via N1 and N3 nitrogen atom acting as a bidentate bridging ligand forming a 1-D polymer. The two solvatomorphs were quantitatively analyzed for the differences with the aid of Hirshfeld surface analysis. (C) 2014 Elsevier B.V. All rights reserved
Simultaneous co-ordination of three cytosine ligands displaying different binding sites around the copper centres
We report the synthesis and structural characterization of a polymeric ternary copper-cytosine-phenanthroline complex, Cu-4(phen)(3)-(mu(3)-cyt)(2)(mu-OH)(cyt)(OH)Cl-3](n)center dot 16H(2)O, where three cytosine ligands with different binding sites have simultaneously complexed to the four copper metal centres. Interestingly, the complex exhibits two different coordination geometries around the metal centres
A Change in the 3(10)- to alpha-Helical Transition Point in the Heptapeptides Containing Sulfur and Selenium
Crystal structures of three heptapeptides Boc-Ala-Leu-Aib-XXX-Ala-Leu-Aib-OMe (where XXX = methionine in peptide A, selenomethionine in peptide B, and S-benzyl cysteine in peptide C) reveal mixed 3(10)-/alpha-helical conformations with R factors of 6.94, 5.79, and 5.98, respectively. All the structures were solved in the P2(1)2(1)2(1) space group. 3(10)- to a-helical transitions are observed in all of these peptides. The helices begin as a 3(10)-helical segment at the N-terminus and then transit for peptides A and C at residue Aib(3) carbonyl (O(3)), while for peptide B the transition occurs at residue Leu(2) carbonyl oxygen (O(2)). There are water molecules associated in the crystal of each of these peptides and they form different types of hydrogen bonding patterns in each crystal. The observations suggest that 3(10)- to alpha-helical transition is sequence dependent in these short heptapeptide sequences
- …